Literature DB >> 9403420

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.

F L Brancati1, P K Whelton, B L Randall, J D Neaton, J Stamler, M J Klag.   

Abstract

CONTEXT: Diabetes is a frequent cause of end-stage renal disease (ESRD). However, the degree of risk is uncertain.
OBJECTIVE: To determine the relative risk (RR) of ESRD related to diabetes in the United States.
DESIGN: Nonconcurrent prospective cohort study. PARTICIPANTS: A total of 332544 men aged 35 to 57 years from 18 US cities screened in 1973 to 1975 for participation in the Multiple Risk Factor Intervention Trial (MRFIT). MAIN EXPOSURE: Diabetes mellitus defined by self-reported use of medication for diabetes at baseline. MAIN OUTCOME: Incident ESRD through 1990 assessed from a national ESRD registry and by surveillance for death from renal disease.
RESULTS: Over an average follow-up of 16 years, there were 136 cases of ESRD in 5147 diabetic men and 678 cases in 327397 nondiabetic men. Age-adjusted incidence of all-cause ESRD in the diabetic men was 199.8 per 100000 person-years compared with 13.7 per 100000 person years in their nondiabetic counterparts (RR, 12.7; 95% confidence interval [CI], 10.5-15.4). Diabetic men were also at higher risk for ESRD ascribed to causes other than diabetes (RR=4.3; 95% CI, 3.2-5.9). With simultaneous adjustment for age, ethnicity, income, blood pressure, serum cholesterol level, and history of myocardial infarction, diabetic men remained at higher risk for all-cause ESRD (RR, 9.0; 95% CI, 7.4-11.0), ESRD ascribed to diabetes (RR, 92.3; 95% CI, 64.6-131.9), and ESRD ascribed to nondiabetic causes (RR, 3.0; 95% CI, 2.2-4.1).
CONCLUSIONS: Diabetes mellitus is a strong independent risk factor for ESRD, even for ESRD ascribed to causes other than diabetes. Improvements in the prevention and control of diabetes should produce substantial reductions in ESRD incidence.

Entities:  

Mesh:

Year:  1997        PMID: 9403420

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  79 in total

1.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

2.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

Review 3.  Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.

Authors:  Rikki M Tanner; Todd M Brown; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 4.  End stage renal disease.

Authors:  Yoshio N Hall; Glenn M Chertow
Journal:  BMJ Clin Evid       Date:  2007-10-17

5.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

6.  The role of renin-angiotensin-aldosterone system genes in the progression of chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Authors:  Tanika N Kelly; Dominic Raj; Mahboob Rahman; Matthias Kretzler; Radhakrishna R Kallem; Ana C Ricardo; Sylvia E Rosas; Kaixiang Tao; Dawei Xie; Lotuce Lee Hamm; Jiang He
Journal:  Nephrol Dial Transplant       Date:  2015-04-23       Impact factor: 5.992

7.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

8.  Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.

Authors:  Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

9.  Clinical value of urinary kidney biomarkers for estimation of renal impairment in elderly Chinese with essential hypertension.

Authors:  Xunhui Xu; Yi Fang; Jun Ji; SuHua Jiang; DingGuang Xing; ShaoHua Fei; XiaoQiang Ding
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 10.  Hippo signaling in the kidney: the good and the bad.

Authors:  Jenny S Wong; Kristin Meliambro; Justina Ray; Kirk N Campbell
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.